Michael Crackower, PhD, Chief Scientific Officer of Ventus Therapeutics, and Jason Burch, PhD, join Vineeta Agarwala, MD, PhD, general partner at a16z Bio + Health.
Together, they talk about how Ventus approaches drug discovery and why they believe we’re in the early stages of small molecule innovation. Specifically, we’ll hear about the ReSOLVE platform, which enables the drug hunting team to more accurately design and iterate on small molecular compounds for therapeutic applications. They also talk about the current candidates in the pipeline and how they’re able to go from idea to IND in record time.
Podden och tillhörande omslagsbild på den här sidan tillhör Andreessen Horowitz, a16z Bio + Health. Innehållet i podden är skapat av Andreessen Horowitz, a16z Bio + Health och inte av, eller tillsammans med, Poddtoppen.
